Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/29435
Başlık: Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetic patients
Yazarlar: Yavuz, Dilek Gogas
Keskin, Lezan
Sert, Murat
Yazıcı, Dilek
Şahin, İbrahim
Yüksel, Meral
Deyneli, Oğuzhan
Aydın, Hasan
Akalın, Sema
Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji Diyabet ve Metabolizma Anabilim Dalı.
Kıyıcı, Sinem
Tuncel, Ercan
12753880400
7006929833
Anahtar kelimeler: Endocrinology & metabolism
Type 1 diabetes
Vitamin D
Vitamin D receptor gene polymorphisms
Bone mineral density
Association
Population
Susceptibility
Osteoporosis
Prevalence
Osteopenia
Mellitus
Health
Onset
Yayın Tarihi: Ara-2011
Yayıncı: Springer
Atıf: Yavuz, D. G. vd. (2011). "Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetic patients". Acta Diabetologica, 48(4), 329-336.
Özet: Previous studies have suggested an influence of vitamin D receptor alleles on bone metabolism and on susceptibility to type 1 diabetes mellitus in different ethnic populations. We aimed to investigate the distribution of vitamin D receptor (VDR) alleles in relation to biochemical bone turnover parameters and bone densitometry measurements in a group of Turkish type 1 diabetic patients. One hundred and seventeen patients (M/F 57/60, 27.6 +/- A 7.3 y duration of diabetes 8.1 +/- A 6.3 y) and 134 healthy controls (M/F 61/73, 26.2 +/- A 5.3 y) were included in the study. Bone mineral density (BMD) was evaluated by dual-energy X-ray absorptiometry (DEXA). The vitamin D receptor gene (VDR) polymorphisms FokI, Bsm1, Apa1, and Taq1 were examined using a PCR-based restriction analysis. Serum levels of calcium, phosphor osteocalcin, intact parathyroid hormone, and C telopeptide were measured. Vitamin D receptor Bsm1 Fok1, Apa1, and Taq1 genotype distributions were not different between patient with diabetes and control groups. BMD was 0.77 +/- A 0.2 g/cm(2) vs. 0.97 +/- A 0.2 g/cm(2) (P = 0.0001) for the femur, 1.0 +/- A 0.1 g/cm(2) vs. 1.13 +/- A 0.1 g/cm(2) (P = 0.001) for type 1 diabetic patients and controls. Bone turnover markers were significantly lower in type 1 diabetic group. BMD measurements and bone metabolic markers were not different between the genotypes in either the patient with diabetes or the controls. The VDR gene polymorphisms, Bsm1, Fok 1, Apa1, and Taq1 showed no influence on bone metabolism in our group of type 1 diabetic patients.
URI: https://doi.org/10.1007/s00592-011-0284-y
https://link.springer.com/article/10.1007/s00592-011-0284-y
http://hdl.handle.net/11452/29435
ISSN: 0940-5429
1432-5233
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.